GENSCRIPT BIO(01548),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01548 GENSCRIPT BIO

Market Closed 03-27 16:08:20

11.100

+0.350

+3.26%

High11.200	Low10.680	Vol8.17M
Open10.850	D1 Closing10.750	Amplitude4.84%
Mkt Cap24.28B	Tradable Cap24.28B	Total Shares2.19B
T/O90.25M	T/O Rate0.37%	Tradable Shares2.19B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01548","market":"HK","secType":"STK","nameCN":"GENSCRIPT BIO","latestPrice":11.1,"timestamp":1774598900002,"preClose":10.75,"halted":0,"volume":8173982,"delay":0,"changeRate":0.032558139534883686,"floatShares":2187000000,"shares":2187000000,"eps":-1.9236638831714628,"marketStatus":"Market Closed","change":0.35,"latestTime":"03-27 16:08:20","open":10.85,"high":11.2,"low":10.68,"amount":90253201,"amplitude":0.048372,"askPrice":11.1,"askSize":32000,"bidPrice":11.09,"bidSize":38000,"shortable":3,"etf":0,"ttmEps":-1.9236638831714628,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774834200000},"marketStatusCode":7,"adr":0,"listingDate":1451404800000,"exchange":"SEHK","adjPreClose":10.75,"openAndCloseTimeList":[[1774575000000,1774584000000],[1774587600000,1774598400000]],"volumeRatio":1.1334052221313662,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01548","defaultTab":"news","newsList":[{"id":"1108591007","title":"GENSCRIPT BIO (01548) 2025 Annual Report Review: Synergistic Growth Across Three Core Businesses Highlights Systemic Competitive Advantages and Long-Term Value","url":"https://stock-news.laohu8.com/highlight/detail?id=1108591007","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108591007?lang=en_us&edition=fundamental","pubTime":"2026-03-18 17:15","pubTimestamp":1773825309,"startTime":"0","endTime":"0","summary":"On March 15, GENSCRIPT BIO (01548) released its full-year financial results for 2025. The past year showcased a clear and robust growth trajectory for the company. As a rapidly expanding enterprise...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","HK0000306701.USD","HK0000306685.HKD","01548","BK1583","BK1576","HK0000320223.HKD","HK0000320264.USD"],"gpt_icon":0},{"id":"1113306341","title":"Daiwa Cuts Target Price for GENSCRIPT BIO (01548) to HK$21, Reiterates \"Buy\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1113306341","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113306341?lang=en_us&edition=fundamental","pubTime":"2026-03-18 14:28","pubTimestamp":1773815299,"startTime":"0","endTime":"0","summary":"Daiwa released a research report indicating that GENSCRIPT BIO (01548) delivered results in line with expectations last year. Sales increased by 61% year-on-year to $960 million, matching the firm's...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","BK1583","HK0000320264.USD","01548","HK0000320223.HKD","BK1141","HK0000306701.USD","HK0000306685.HKD"],"gpt_icon":0},{"id":"1171648273","title":"Revised title","url":"https://stock-news.laohu8.com/highlight/detail?id=1171648273","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171648273?lang=en_us&edition=fundamental","pubTime":"2026-03-18 12:00","pubTimestamp":1773806447,"startTime":"0","endTime":"0","summary":"CICC Maintains Outperform Rating on GENSCRIPT BIO but Cuts Target Price to HK$17.90","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","BK1583","HK0000320264.USD","01548","HK0000320223.HKD","BK1141","HK0000306701.USD","HK0000306685.HKD"],"gpt_icon":0},{"id":"2620470178","title":"Genscript Biotech Losses Narrow Sharply In First Half Reinforcing Profitability Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2620470178","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620470178?lang=en_us&edition=fundamental","pubTime":"2026-03-18 01:15","pubTimestamp":1773767728,"startTime":"0","endTime":"0","summary":"Genscript Biotech (SEHK:1548) has reported its FY 2025 numbers with first half revenue of US$518.8 million and a basic EPS loss of US$0.01, alongside a trailing twelve month EPS loss of US$0.25 on revenue of US$959.5 million. Over the past three first half periods, revenue has moved from US$391.3 million in 2023 to US$285.2 million in 2024 and then to US$518.8 million in 2025, while basic EPS has ranged from a loss of US$0.04 in both 2023 and 2024 to a smaller loss of US$0.01 in 2025. With...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1548/genscript-biotech-shares/news/genscript-biotech-losses-narrow-sharply-in-first-half-reinfo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1548/genscript-biotech-shares/news/genscript-biotech-losses-narrow-sharply-in-first-half-reinfo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4581","01548","HK0000320223.HKD","XBI","BK1576","BK1141","HK0000306701.USD","BK4588","BK4585","BK1583","HK0000306685.HKD","HK0000320264.USD"],"gpt_icon":0},{"id":"1122455261","title":"GENSCRIPT BIO (01548) Surges Over 5% on Strong Annual Revenue Growth and Narrowed Losses at Legend Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=1122455261","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122455261?lang=en_us&edition=fundamental","pubTime":"2026-03-17 11:23","pubTimestamp":1773717798,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO (01548) saw its shares rise more than 5% in Hong Kong trading. At the time of writing, the stock was up 3.24%, trading at HKD 66.95, with a turnover of HKD 62.81 million. The movement...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000306685.HKD","01548","BK4505","HK0000306701.USD","BK4139","BK4585","VXUS","HK0000320223.HKD","LEGN","BK1141","BK1583","BK4588","HK0000320264.USD","BK1576"],"gpt_icon":0},{"id":"1145814400","title":"Stock Track | GENSCRIPT BIO Soars 5.08% Intraday on Underlying Sales Growth and European mRNA Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1145814400","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145814400?lang=en_us&edition=fundamental","pubTime":"2026-03-17 10:06","pubTimestamp":1773713207,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO's stock price surged 5.08% during intraday trading on Tuesday, marking a significant upward movement for the biotechnology company.The movement appears linked to the market's assessment...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01548"],"gpt_icon":0},{"id":"2620496309","title":"Genscript’s 2025 Profit Swing And mRNA Expansion Might Change The Case For Investing In Genscript Biotech (SEHK:1548)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620496309","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620496309?lang=en_us&edition=fundamental","pubTime":"2026-03-17 00:13","pubTimestamp":1773677581,"startTime":"0","endTime":"0","summary":"Genscript Biotech has reported its full-year 2025 results, with sales rising to US$959.53 million while the company moved from a prior-year net income of US$2.96 billion to a net loss of US$532.83 million, alongside higher basic and diluted losses per share.\nA key driver of this sharp swing in reported profitability is the absence of the previous year’s very large one-time unrealised gain from deconsolidation, which means the latest figures chiefly reflect the underlying operating profile...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1548/genscript-biotech-shares/news/genscripts-2025-profit-swing-and-mrna-expansion-might-change","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1548/genscript-biotech-shares/news/genscripts-2025-profit-swing-and-mrna-expansion-might-change","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1576","BK1583","BK1141","HK0000320223.HKD","BK4588","HK0000320264.USD","BK4581","XBI","BK4585","HK0000306685.HKD","01548","HK0000306701.USD"],"gpt_icon":0},{"id":"2619454559","title":"BRIEF-Genscript Biotech Corp Reports Strong Fy2025 Results As Integrated Platform Strategy And Global Execution Drive High-Quality Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2619454559","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619454559?lang=en_us&edition=fundamental","pubTime":"2026-03-16 18:36","pubTimestamp":1773657410,"startTime":"0","endTime":"0","summary":"BRIEF-Genscript Biotech Corp Reports Strong Fy2025 Results As Integrated Platform Strategy And Global Execution Drive High-Quality GrowthMarch 16 (Reuters) - Genscript Biotech Corp 1548.HK:GENSCRIPT B","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nTUARSJ6Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320223.HKD","HK0000320264.USD","BK1583","HK0000306685.HKD","BK1141","01548","BK1576","HK0000306701.USD"],"gpt_icon":0},{"id":"2619800451","title":"Genscript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2619800451","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619800451?lang=en_us&edition=fundamental","pubTime":"2026-03-16 18:10","pubTimestamp":1773655849,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nTUARSJ6Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","HK0000306701.USD","01548","HK0000306685.HKD","BK1583","BK1576","HK0000320223.HKD","HK0000320264.USD"],"gpt_icon":0},{"id":"1171208125","title":"GENSCRIPT BIO (01548.HK) Announces Company Secretary Transition: Sophie Lam Appointed, Wai Ling Wong Resigns","url":"https://stock-news.laohu8.com/highlight/detail?id=1171208125","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171208125?lang=en_us&edition=fundamental","pubTime":"2026-03-15 20:01","pubTimestamp":1773576090,"startTime":"0","endTime":"0","summary":"Genscript Biotech Corporation (stock code: 01548) has disclosed a senior management change effective 15 March 2026. Ms. Wong Wai Ling has tendered her resignation as Company Secretary and Authorised...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"gpt_icon":0},{"id":"1174684345","title":"GENSCRIPT BIO (01548) Appoints New Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1174684345","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174684345?lang=en_us&edition=fundamental","pubTime":"2026-03-15 19:34","pubTimestamp":1773574458,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO (01548) has announced the resignation of Ms. Huang Huiling from her roles as Company Secretary and Authorized Representative under the Hong Kong Companies Ordinance, effective March 15,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1576","HK0000306701.USD","HK0000320223.HKD","01548","HK0000306685.HKD","BK1583","HK0000320264.USD"],"gpt_icon":0},{"id":"2619106634","title":"GenScript Biotech appoints Lam Wai Yee Sophie as company secretary, replacing Wong Wai Ling","url":"https://stock-news.laohu8.com/highlight/detail?id=2619106634","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619106634?lang=en_us&edition=fundamental","pubTime":"2026-03-15 19:26","pubTimestamp":1773574014,"startTime":"0","endTime":"0","summary":"GenScript said Wai Ling Wong resigned as company secretary. The company also said Sophie Lam was appointed company secretary. Lam is a vice president in the listed corporate secretarial department at SWCS Corporate Services Group in Hong Kong. She has more than 20 years of experience in company secretarial and compliance work.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 15, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260315:nNDL6wZr87:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1583","01548","HK0000320223.HKD","HK0000306685.HKD","HK0000306701.USD","BK1576","HK0000320264.USD"],"gpt_icon":0},{"id":"2619105282","title":"GenScript Biotech FY2025 adjusted net profit tripled to USD 230.35 million, revenue rose 61% to USD 959.53 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2619105282","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619105282?lang=en_us&edition=fundamental","pubTime":"2026-03-15 18:49","pubTimestamp":1773571744,"startTime":"0","endTime":"0","summary":"GenScript published its annual results announcement for the year ended 31 December 2025. Revenue from continuing operations rose 61% to USD 959.53 million, and gross profit more than doubled to USD 553.2 million. Adjusted net profit from continuing operations rose more than doubled to USD 230.35 million, while loss after income tax widened 206% to USD 532.4 million. The company said the net loss was mainly driven by its investment in Legend, including a USD 320.4 million share of loss and a USD 398.07 million non-cash impairment. Cash and bank balances and wealth management financial products increased 14% to USD 843.09 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260315:nNDL13Kk6k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320264.USD","HK0000320223.HKD","BK1141","BK1583","BK1576","HK0000306685.HKD","01548","HK0000306701.USD"],"gpt_icon":0},{"id":"1175169999","title":"Morgan Stanley Adjusts GENSCRIPT BIO (01548) Target Price to HK$16.5, Keeps \"Overweight\" Stance","url":"https://stock-news.laohu8.com/highlight/detail?id=1175169999","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175169999?lang=en_us&edition=fundamental","pubTime":"2026-03-11 15:48","pubTimestamp":1773215295,"startTime":"0","endTime":"0","summary":"Following a profit warning issued by GENSCRIPT BIO (01548), Morgan Stanley has revised its earnings forecasts for the period 2026 to 2030 downward by 1% to 13%. In response, the firm has lowered its target price from HK$18.3 to HK$16.5, while maintaining an \"Overweight\" rating on the stock.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","HK0000306685.HKD","01548","HK0000320264.USD","HK0000320223.HKD","HK0000306701.USD","BK1576","BK1141"],"gpt_icon":0},{"id":"2618199496","title":"Genscript Biotech Forecasts 2025 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2618199496","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618199496?lang=en_us&edition=fundamental","pubTime":"2026-03-11 11:14","pubTimestamp":1773198882,"startTime":"0","endTime":"0","summary":"Genscript Biotech  said it expects $505.8 million to $585.6 million in loss for 2025, compared with a profit of $2.9 billion in 2024, according to a Hong Kong bourse filing Tuesday.Shares of the life sciences firm fell over 1% in morning trade Wednesday.The firm attributed the reversal of profit to a high base effect in 2024 which included a one-time unrealized gain of around $3.2 billion.Genscript also expects to record $256.1 million to $298.8 million in license revenue for the year, compared to $2.4 million in 2024.The company's financial results are due by the end of March.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HK0000320264.USD","HK0000320223.HKD","BK1141","BK1583","BK1576","01548","HK0000306685.HKD","BK4581","XBI","HK0000306701.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"1172206689","title":"GENSCRIPT BIO (01548) Issues Profit Warning: FY2025 Swings to Up to US$585.60 Million Loss Despite Tripling Adjusted Net Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1172206689","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172206689?lang=en_us&edition=fundamental","pubTime":"2026-03-10 22:42","pubTimestamp":1773153762,"startTime":"0","endTime":"0","summary":"Genscript Biotech Corporation (stock code: 01548) released a profit warning for the year ended 31 December 2025, outlining a mixed performance driven by surging license revenue but weighed down by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"gpt_icon":0},{"id":"1133299326","title":"GENSCRIPT BIO Issues Profit Warning, Anticipates $506-586 Million Loss for 2025 Fiscal Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1133299326","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133299326?lang=en_us&edition=fundamental","pubTime":"2026-03-10 22:40","pubTimestamp":1773153627,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO (01548) has announced a profit warning for the fiscal year ending December 31, 2025. The company expects to report a significant net loss for the period. For the reporting period, the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","BK1141","HK0000306685.HKD","BK1583","01548","HK0000320223.HKD","HK0000320264.USD","HK0000306701.USD"],"gpt_icon":0},{"id":"2618095942","title":"GenScript Biotech expects FY2025 adjusted net profit of USD 207.3-241.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2618095942","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618095942?lang=en_us&edition=fundamental","pubTime":"2026-03-10 22:27","pubTimestamp":1773152873,"startTime":"0","endTime":"0","summary":"GenScript said adjusted net profit from continuing operations for FY2025 is expected at about USD 207.3 million to USD 241.9 million, versus about USD 59.8 million a year earlier. It expects license revenue of about USD 256.1 million to USD 298.8 million, compared with about USD 2.4 million in the prior period. The group expects a non-cash share of loss from Legend of about USD 304.4 million to USD 352.4 million and an impairment of its investment in Legend of about USD 378.2 million to USD 437.9 million. GenScript expects an FY2025 loss of about USD 505.8 million to USD 585.6 million, versus a profit of about USD 2.9 billion in the prior period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nNDL7cTDRM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548","HK0000320264.USD","BK1576","HK0000320223.HKD","BK1583","BK1141","HK0000306685.HKD","HK0000306701.USD"],"gpt_icon":0},{"id":"2618695942","title":"Genscript Biotech - Adj Net Profit for FY2025 Expected at US$207.3 Mln-US$241.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2618695942","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618695942?lang=en_us&edition=fundamental","pubTime":"2026-03-10 22:27","pubTimestamp":1773152848,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY1FC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01548","HK0000320223.HKD","BK1141","BK1583","BK1576","HK0000306685.HKD","HK0000320264.USD","HK0000306701.USD"],"gpt_icon":0},{"id":"1170993960","title":"GENSCRIPT BIO (01548) Schedules Board Meeting for 15 March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1170993960","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170993960?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:03","pubTimestamp":1772615024,"startTime":"0","endTime":"0","summary":"GENSCRIPT BIO (01548) has announced that a Board meeting will be held on 15 March 2026. The main objectives include reviewing and approving annual results for the year ended 31 December 2025,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01548"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.genscript.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0924},{"period":"3month","weight":-0.1494},{"period":"6month","weight":-0.2921},{"period":"1year","weight":-0.1091},{"period":"ytd","weight":-0.1063}],"compareEarnings":[{"period":"1week","weight":-0.0129},{"period":"1month","weight":-0.0678},{"period":"3month","weight":-0.0336},{"period":"6month","weight":-0.045},{"period":"1year","weight":0.0582},{"period":"ytd","weight":-0.0265}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Genscript Biotech Corp is an investment holding company principally engaged in the manufacture and sale of life science research products and services. The Company operates its businesses through five segments. The Life-science Services and Products segment provides comprehensive research services and products. The Biologics Development Services segment provides comprehensive services to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene, cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment provides industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The Cell Therapy segment discovers and develops CAR-T therapies for the treatment of liquid and solid tumors. The Operation segment provides shared services to other segments. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.000341},{"month":2,"riseRate":0.545455,"avgChangeRate":0.075475},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.059433},{"month":4,"riseRate":0.5,"avgChangeRate":0.038375},{"month":5,"riseRate":0.5,"avgChangeRate":0.068155},{"month":6,"riseRate":0.6,"avgChangeRate":0.044564},{"month":7,"riseRate":0.6,"avgChangeRate":0.075818},{"month":8,"riseRate":0.4,"avgChangeRate":0.101263},{"month":9,"riseRate":0.4,"avgChangeRate":-0.071937},{"month":10,"riseRate":0.6,"avgChangeRate":0.095918},{"month":11,"riseRate":0.6,"avgChangeRate":0.045101},{"month":12,"riseRate":0.3,"avgChangeRate":0.042047}],"exchange":"SEHK","name":"GENSCRIPT BIO","nameEN":"GENSCRIPT BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GENSCRIPT BIO(01548),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GENSCRIPT BIO(01548) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GENSCRIPT BIO,01548,GENSCRIPT BIO股票,GENSCRIPT BIO股票老虎,GENSCRIPT BIO股票老虎国际,GENSCRIPT BIO行情,GENSCRIPT BIO股票行情,GENSCRIPT BIO股价,GENSCRIPT BIO股市,GENSCRIPT BIO股票价格,GENSCRIPT BIO股票交易,GENSCRIPT BIO股票购买,GENSCRIPT BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GENSCRIPT BIO(01548),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GENSCRIPT BIO(01548) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}